Last reviewed · How we verify
Radical prostatectomy with implantation of allograft
Radical prostatectomy with implantation of allograft is a Biologic drug developed by Kantonsspital Winterthur KSW. It is currently FDA-approved.
At a glance
| Generic name | Radical prostatectomy with implantation of allograft |
|---|---|
| Sponsor | Kantonsspital Winterthur KSW |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluating Return to Continence and Potency Following Radical Prostatectomy (NA)
- Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Radical prostatectomy with implantation of allograft CI brief — competitive landscape report
- Radical prostatectomy with implantation of allograft updates RSS · CI watch RSS
- Kantonsspital Winterthur KSW portfolio CI
Frequently asked questions about Radical prostatectomy with implantation of allograft
What is Radical prostatectomy with implantation of allograft?
Radical prostatectomy with implantation of allograft is a Biologic drug developed by Kantonsspital Winterthur KSW.
Who makes Radical prostatectomy with implantation of allograft?
Radical prostatectomy with implantation of allograft is developed and marketed by Kantonsspital Winterthur KSW (see full Kantonsspital Winterthur KSW pipeline at /company/kantonsspital-winterthur-ksw).
What development phase is Radical prostatectomy with implantation of allograft in?
Radical prostatectomy with implantation of allograft is FDA-approved (marketed).